AEON Biopharma, Inc.
Net BuyingAEON·US·🇺🇸 US
75%buys·25%sells
114 transactions$85KTotal buys·3 buys
$73.8MTotal sells·1 sell
1515 insiders
Last: Apr 2, 2026
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Apr 2, 26 | Bencich John | Grant | - | |
| May 21, 25 | FISCHER JOST | Grant | - | |
| May 21, 25 | Carter Eric G | Grant | - | |
| May 21, 25 | PALMISANO ROBERT J | Grant | - | |
| May 21, 25 | Forth Marc | Grant | - | |
| May 21, 25 | Sy Jennifer | Grant | - | |
| May 21, 25 | Oh Chad | Grant | - | |
| May 21, 25 | Wilson Alexander Blair | Grant | - | |
| May 21, 25 | Thunen Shelley B | Grant | - | |
| May 21, 25 | FISCHER JOST | Buy | $29K |
AEON Biopharma, Inc. (AEON) has recorded 114 insider transactions from 15 insiders. Total insider buying volume stands at $85K, while total selling volume is $73.8M. Overall insider sentiment is bullish (75% purchases).
AEON Biopharma, Inc. (AEON) has recorded 114 insider operations, including 3 open-market purchases ($85K), 1 sales ($73.8M) and 110 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bullish (75% purchases).
Recent activity is concentrated over 3 months in the last year.
Among the most active insiders are Forth Marc (CEO), Bancroft Robert E. (CEO) & Bencich John (CFO), with respectively 10, 2, 77 transactions.
Across all 114 recorded transactions, the breakdown by type is: grant (67, 59%), exercise (40, 35%), other (3, 3%), buys (3, 3%), sells (1, 1%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
AEON Biopharma, Inc. has recorded 114 insider operations in total, including 3 open-market purchases ($85K), 1 sales ($73.8M) and 110 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on April 2, 2026.
Insiders at AEON Biopharma, Inc. are currently net buyers, with 75% purchases and 25% sales across all reported transactions. Total buy volume is $85K versus $73.8M in sales, indicating a bullish insider sentiment.
InsiderLens tracks 15 insiders at AEON Biopharma, Inc. (AEON). Forth Marc (CEO, 10 tx), Bancroft Robert E. (CEO, 2 tx), Bencich John (CFO, 77 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for AEON is bullish, based on a 75% buy ratio across 4 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for AEON Biopharma, Inc. comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.